Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of nephrotoxicity of gentamicin and amikacin in infected neonates
IRCT2016052828122N1Phase 2Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Apr 2016
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of gentamicin and amikacin in neonatal infection (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoint: Nephrotoxicity comparison. Started Apr 2016; status: completed.
02
Drugs
gentamicinamikacin
03
Conditions
neonatal infection
Beyond the preview
Go deeper on IRCT2016052828122N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016052828122N1.